Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 676.9Cr 100.33Cr 87Cr 81Cr 75Cr 140.64Cr 9.56TCr 143.39Cr 957.11Cr 374.82Cr 4.76TCr 376.79Cr 368.52Cr 16TCr P/E 2026 *
12.6x
P/E 2027 * 10.6x
Enterprise Value 542.93Cr 80Cr 70Cr 65Cr 60Cr 112.8Cr 7.67TCr 115.01Cr 767.68Cr 300.64Cr 3.82TCr 302.21Cr 295.58Cr 13TCr EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.27x
Free-Float
51.88%
Yield 2026 *
4.02%
Yield 2027 * 4.53%
1 day+1.03%
1 week+7.67%
Current month+1.03%
1 month+15.93%
3 months-7.02%
6 months-14.19%
Current year-8.32%
1 week 11.17
Extreme 11.17
11.85
1 month 9.9
Extreme 9.9
11.85
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.66
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
11/05/26 Buy

Founder

43,71,400 1.0926%
18/12/25 Buy

Founder

15,50,700 0.3876%
17/12/25 Buy

Founder

20,04,500 0.5010%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%+7.67%-22.08%-53.18% 99Cr
+1.02%+7.57%-18.36%-26.36% 1.6TCr
+0.70%+8.23%-25.00%-32.68% 740.06Cr
-1.54%+1.50%-20.60%-7.52% 625.54Cr
-0.09%+4.27%-6.20%-30.00% 407.97Cr
0.00%+3.23%-22.46%-43.73% 332.3Cr
-1.86%+0.54%+6.20%-35.63% 317.81Cr
+1.37%+3.90%-41.35%-21.77% 311.7Cr
-1.84%+0.18%-12.18%+5.48% 270.01Cr
+3.24%+0.89%+100.74% - 250.31Cr
Average +0.20%+2.30%-6.13%-27.27% 495.75Cr
Weighted average by Cap. +0.28%+3.88%-12.50%-25.45%

Financials

2026 *2027 *
Net sales 1.8TCr 267.51Cr 231.96Cr 216.27Cr 198.73Cr 374.97Cr 26TCr 382.3Cr 2.55TCr 999.36Cr 13TCr 1TCr 982.55Cr 42TCr 1.92TCr 283.98Cr 246.24Cr 229.59Cr 210.96Cr 398.05Cr 27TCr 405.83Cr 2.71TCr 1.06TCr 13TCr 1.07TCr 1.04TCr 45TCr
Net income 55Cr 8.08Cr 7.01Cr 6.53Cr 6Cr 11Cr 770.25Cr 12Cr 77Cr 30Cr 383.34Cr 30Cr 30Cr 1.27TCr 65Cr 9.63Cr 8.35Cr 7.79Cr 7.15Cr 13Cr 917.97Cr 14Cr 92Cr 36Cr 456.85Cr 36Cr 35Cr 1.51TCr
Net Debt -133.97Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -189.43Cr -74Cr -942.11Cr -75Cr -73Cr -3.12TCr -163.03Cr -24Cr -21Cr -20Cr -18Cr -34Cr -2.3TCr -35Cr -230.52Cr -90Cr -1.15TCr -91Cr -89Cr -3.8TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
03/26/03 CN¥11.79 +1.03% 80,60,896
31/26/31 CN¥11.67 -0.09% 93,31,151
30/26/30 CN¥11.68 +0.78% 97,86,552
29/26/29 CN¥11.59 +2.02% 96,52,539
28/26/28 CN¥11.36 +0.26% 75,99,300
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.79CNY
Average target price
14.86CNY
Spread / Average Target
+26.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock